Identification a novel clinical biomarker in early diagnosis of human non-small cell lung cancer

Prognostic value of baseline carcinoembryonic antigen and cytokeratin 19 fragment levels in advanced non-small cell lung cancer

(2018) Ae Rin Baek et al.   Cancer Biomarkers

Isomer-specific profiling of N-glycans derived from human serum for potential biomarker discovery in pancreatic cancer

(2018) Yufei Liu et al.   Journal of Proteomics

A multi-omic study reveals BTG2 as a reliable prognostic marker for early-stage non-small cell lung cancer

(2018) Sipeng Shen et al.   Molecular Oncology

Paraoxonase-1 (PON1) induces metastatic potential and apoptosis escape via its antioxidative function in lung cancer cells

(2017) Mark Borris D. Aldonza et al.   Oncotarget

Paraoxonase 1 gene polymorphisms are associated with an increased risk of breast cancer in a population of Chinese women

(2017) Junrong Wu et al.   Oncotarget

Identification of GlcNAcylated alpha-1-antichymotrypsin as an early biomarker in human non-small-cell lung cancer by quantitative proteomic analysis with two lectins

(2016) Yanxia Jin et al.   BRITISH JOURNAL OF CANCER

Identification of Novel N-Glycosylation Sites at Noncanonical Protein Consensus Motifs

(2016) Mark S. Lowenthal et al.   JOURNAL OF PROTEOME RESEARCH

Improvement of core-fucosylated glycoproteome coverage via alternating HCD and ETD fragmentation

(2016) Cheng Ma et al.   Journal of Proteomics

Characteristics of Smoking Patients with Lung Cancer with Emphysematous Bullae

(2016) Eiji Iwama et al.   Journal of Thoracic Oncology

Identification and Validation of Atypical N-Glycosylation Sites

(2015) Shisheng Sun et al.   ANALYTICAL CHEMISTRY

Early Detection of Lung Cancer in Serum by a Panel of MicroRNA Biomarkers

(2015) Ping Wang et al.   Clinical Lung Cancer

Serum fucosylated paraoxonase 1 as a potential glycobiomarker for clinical diagnosis of early hepatocellular carcinoma using ELISA Index

(2015) Shu Zhang et al.   GLYCOCONJUGATE JOURNAL

Morphological and genetic classification of lung cancer: variation in practice and implications for tailored treatment

(2015) Paul Cane et al.   HISTOPATHOLOGY

GM2-Activator Protein: A New Biomarker for Lung Cancer

(2015) Laddawan Potprommanee et al.   Journal of Thoracic Oncology

Genomic alterations in lung adenocarcinoma

(2015) Siddhartha Devarakonda et al.   LANCET ONCOLOGY

Temporal trends in the incidence and relative survival of non-small cell lung cancer in Canada: A population-based study

(2015) Noori Akhtar-Danesh et al.   LUNG CANCER

Differentially expressed glycosylated patterns of α-1-antitrypsin as serum biomarkers for the diagnosis of lung cancer

(2014) Yiqian Liang et al.   GLYCOBIOLOGY

Comprehensive Analysis of Oncogenic Mutations in Lung Squamous Cell Carcinoma With Minor Glandular Component

(2013) Yunjian Pan et al.   CHEST

Altered Expression of Sialylated Glycoproteins in Ovarian Cancer Sera Using Lectin-based ELISA Assay and Quantitative Glycoproteomics Analysis

(2013) Jing Wu et al.   JOURNAL OF PROTEOME RESEARCH

Quantitative Proteomic Analysis Identified Paraoxonase 1 as a Novel Serum Biomarker for Microvascular Invasion in Hepatocellular Carcinoma

(2013) Cheng Huang et al.   JOURNAL OF PROTEOME RESEARCH

Quantitative proteomic investigation employing stable isotope labeling by peptide dimethylation on proteins of strawberry fruit at different ripening stages

(2013) Li Li et al.   Journal of Proteomics

Integrated Glycoproteomics Demonstrates Fucosylated Serum Paraoxonase 1 Alterations in Small Cell Lung Cancer

(2013) Jung-Mo Ahn et al.   MOLECULAR & CELLULAR PROTEOMICS

Serum paraoxonase 1 heteroplasmon, a fucosylated, and sialylated glycoprotein in distinguishing early hepatocellular carcinoma from liver cirrhosis patients

(2012) Chun Sun et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

A novel lectin fromAgrocybe aegeritashows high binding selectivity for terminalN-acetylglucosamine

(2012) Shuai Jiang et al.   BIOCHEMICAL JOURNAL

Epigenetic biomarkers in lung cancer

(2012) Triantafillos Liloglou et al.   CANCER LETTERS

The State of Molecular Biomarkers for the Early Detection of Lung Cancer

(2012) M. Hassanein et al.   Cancer Prevention Research

Lectin Chromatography/Mass Spectrometry Discovery Workflow Identifies Putative Biomarkers of Aggressive Breast Cancers

(2012) Penelope M. Drake et al.   JOURNAL OF PROTEOME RESEARCH

Development of an AlphaLISA assay to quantify serum core-fucosylated E-cadherin as a metastatic lung adenocarcinoma biomarker

(2012) Chu-Ling Wen et al.   Journal of Proteomics

Mass spectrometry-based proteomics: The road to lung cancer biomarker discovery

(2012) Paola Indovina et al.   MASS SPECTROMETRY REVIEWS

Precision Mapping of an In Vivo N-Glycoproteome Reveals Rigid Topological and Sequence Constraints

(2010) Dorota F. Zielinska et al.   CELL

Analysis of the Human Cancer Glycome Identifies a Novel Group of Tumor-Associated N-Acetylglucosamine Glycan Antigens

(2009) T. Satomaa et al.   CANCER RESEARCH

The challenge of classifying poorly differentiated tumours in the lung

(2009) William A H Wallace   HISTOPATHOLOGY

Baseline and salt-stimulated paraoxonase and arylesterase activities in patients with chronic liver disease: relation to disease severity

(2009) M. Keskin et al.   INTERNAL MEDICINE JOURNAL

Multiplex peptide stable isotope dimethyl labeling for quantitative proteomics

(2009) Paul J Boersema et al.   Nature Protocols

A review of novel biological tools used in screening for the early detection of lung cancer

(2009) R Ghosal et al.   POSTGRADUATE MEDICAL JOURNAL